Contagious Fungal Infections Undiagnosed Amidst COVID-19 Pandemic

Fungal Infections
Fungal Infections

United States: Amidst the initial years of the COVID-19 pandemic in the United States, a recent inquiry highlighted fungal infections, which can induce severe respiratory ailments and even mortality, were not adequately diagnosed and reported. The study findings were disseminated through the Morbidity and Mortality Weekly Report.

Indications and presentations of them indicate a number of similar different diseases.

Mycotic risings such as pinocytosis, cytoplasm, and blastomycosis stand as fungal disease organisms capable of invading the lower respiratory tract, especially if they mimic the symptoms of common pneumonia, which prevail among bacterial and viral infections simultaneously. Even though, in some cases, it could end up being only in the form of mild to moderate disease progression, some fungal infections can also grow into the severe form of disseminated disease, which may eventually lead to fatalities, according to

The prevalence of Coccidioidomycosis primarily resides in the Southwest, while Histoplasmosis and Blastomycosis are found to be prevalent in central and eastern states, as delineated by the authors. Infection typically occurs following the inhalation of spores.

Even preceding the emergence of COVID-19, diagnosing these conditions posed significant challenges, which were further compounded by the pandemic’s advent.

“The clinical indicators and symptoms often mirror those of alternative respiratory infections, including COVID-19 and bacterial or viral community-acquired pneumonia, alongside potential complexities in accessing and interpreting laboratory examinations,” elucidated the authors.

The investigation, involving all these years, 2019, 2020, and 2021, was established to peruse the effects of the pandemic on fungal infection reporting. West Nile virus cases constituted data in 40 states, meningitis cases in Pennsylvania, and cases of multi-drug resistant tuberculosis noticed in 18 states. Americans also recorded cases of Coccidioidomycosis in 26 states, histoplasmosis cases in 13 states, and blastomycosis in 5 states.

If there are no seasonal variations, then 2020 is the year we should be ready for these changes.

Across the three-year period, a cumulative count of 59,655 coccidioidomycosis cases surfaced: For 2019, there were 20,061 cases; the following year, it was 19,284, and then 20,320 in 2021. Similarly, the H-index score of histoplasmosis (1,124, 1,012, and 1,459) was far higher than that for the mycobacterial group (240, 238, 241), as per

Fungal Infections
Fungal Infections

No report by the authors during the period 2020 associated with a reduction of the cases of Coccidioidomycosis and blastomycosis closely compares with the significant rise of cases in the histoplasmosis disease in 2021. The reduction of fungal disease frequency coincides with face-covering wear, as well as with the limitations on the part of traveling to the regions where these fungi live. The increase in the number of patients with histoplasmosis accounts for higher outdoor activities in 2021.

Throughout 2020, fewer instances of each malady were noted during the spring compared to other seasons, hinting at a seasonal disruption initiated by the pandemic’s onset. Case distributions exhibited a more uniform seasonal spread in 2019 and 2021.

Across the study duration, all case-fatality rates (CFR) remained relatively stable, barring blastomycosis, which exhibited a nearly twofold increase from 9% in 2019 and 2020 to 17% in 2021. The typical CFR for blastomycosis ranges from 8% to 10%, as outlined by the authors, reported.

The authors concluded, “Elevated awareness is imperative to enhance the prompt identification and management of Coccidioidomycosis, histoplasmosis, and blastomycosis, especially during heightened occurrences of other respiratory ailments. Establishing standardized diagnostic protocols and disseminating informational reservoirs for pan-respiratory testing, inclusive of fungal infections, is essential and could be assimilated into broader respiratory disease awareness and readiness initiatives.


Please enter your comment!
Please enter your name here